• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白原和 C-反应蛋白对 2 型糖尿病外周动脉疾病进展的影响:初步报告。

Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report.

机构信息

Medical Faculty, University Cardiology Clinic, Skopje, Macedonia.

出版信息

Cardiovasc Diabetol. 2013 Feb 1;12:29. doi: 10.1186/1475-2840-12-29.

DOI:10.1186/1475-2840-12-29
PMID:23375154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3598335/
Abstract

BACKGROUND

Limited studies have suggested that inflammatory biomarkers play a role in the initiation and progression of atherosclerosis in diabetic patients. This study assesses the effect of inflammatory biomarkers: fibrinogen and C-reactive protein (C-RP) on the progression of peripheral arterial disease (PAD) in type 2 diabetic (T2D) patients.

METHODS

Sixty two patients with T2D and PAD (mean age 60.28 ± 27 years and diabetes duration of 8.58 ± 6.17 years) were enrolled in a cohort prospective study of 36 months. Ankle-brachial index (ABI) was measured in all patients at baseline and after 36 months. Multiple linear regression analysis was used to determine the predictivity of variables for fibrinogen, C-RP, plasma lipid fractions, fasting plasma glucose, Body Mass Index (BMI), duration of diabetes status and the age on changes in ABI value.

RESULTS

Linear regression analysis defined F as a predictor for endpoint value of ABI (β = 0.469, p = 0.007). Value of C-RP determinates change of minimal value of ABI (β = 0.449, p = 0.037) and change of mean ABI per year (β = 0.442, p = 0.025).

CONCLUSION

Our data indicate that plasma determination of fibrinogen and C-RP might have a clinical implication in defining the process of progression of PAD in T2D population.

摘要

背景

有限的研究表明,炎症生物标志物在糖尿病患者动脉粥样硬化的发生和发展中起作用。本研究评估了炎症生物标志物:纤维蛋白原和 C 反应蛋白(C-RP)对 2 型糖尿病(T2D)患者外周动脉疾病(PAD)进展的影响。

方法

62 例 T2D 合并 PAD 患者(平均年龄 60.28±27 岁,糖尿病病程 8.58±6.17 年)纳入了一项为期 36 个月的前瞻性队列研究。所有患者在基线和 36 个月时均测量踝臂指数(ABI)。多元线性回归分析用于确定纤维蛋白原、C-RP、血浆脂质成分、空腹血糖、体重指数(BMI)、糖尿病病程和年龄对 ABI 值变化的预测能力。

结果

线性回归分析将 F 定义为 ABI 终点值的预测因子(β=0.469,p=0.007)。C-RP 值决定了 ABI 最小值的变化(β=0.449,p=0.037)和 ABI 每年的平均变化(β=0.442,p=0.025)。

结论

我们的数据表明,血浆纤维蛋白原和 C-RP 的测定可能对定义 T2D 人群 PAD 进展过程具有临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f9/3598335/ca67d2dd4d56/1475-2840-12-29-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f9/3598335/d4a9c9cffc4a/1475-2840-12-29-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f9/3598335/ca67d2dd4d56/1475-2840-12-29-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f9/3598335/d4a9c9cffc4a/1475-2840-12-29-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f9/3598335/ca67d2dd4d56/1475-2840-12-29-2.jpg

相似文献

1
Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report.纤维蛋白原和 C-反应蛋白对 2 型糖尿病外周动脉疾病进展的影响:初步报告。
Cardiovasc Diabetol. 2013 Feb 1;12:29. doi: 10.1186/1475-2840-12-29.
2
Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.胰岛素抵抗与心血管健康研究中的外周动脉疾病事件。
Vasc Med. 2012 Apr;17(2):85-93. doi: 10.1177/1358863X11436195. Epub 2012 Mar 8.
3
Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.2型糖尿病患者中骨保护素与外周动脉疾病的关联
Arch Cardiovasc Dis. 2015 Aug-Sep;108(8-9):412-9. doi: 10.1016/j.acvd.2015.01.015. Epub 2015 Jul 13.
4
Elevation of a novel angiogenic factor, leucine-rich-α2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes.一种新型血管生成因子富含亮氨酸的α2-糖蛋白(LRG1)水平升高与2型糖尿病患者的动脉僵硬度、内皮功能障碍和外周动脉疾病相关。
J Clin Endocrinol Metab. 2015 Apr;100(4):1586-93. doi: 10.1210/jc.2014-3855. Epub 2015 Jan 30.
5
Use of the ankle-brachial index combined with the percentage of mean arterial pressure at the ankle to improve prediction of all-cause mortality in type 2 diabetes mellitus: an observational study.利用踝臂指数结合踝部平均动脉压的百分率提高 2 型糖尿病全因死亡率的预测:一项观察性研究。
Cardiovasc Diabetol. 2020 Oct 9;19(1):173. doi: 10.1186/s12933-020-01149-7.
6
Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.2型糖尿病患者外周动脉疾病的患病率及其与冠状动脉疾病及其危险因素的相关性。
J Assoc Physicians India. 2012 Jul;60:28-32.
7
Association of Serum Uric Acid Levels with Leg Ischemia in Patients with Peripheral Arterial Disease after Treatment.治疗后外周动脉疾病患者血清尿酸水平与下肢缺血的相关性
J Atheroscler Thromb. 2017 Jul 1;24(7):725-734. doi: 10.5551/jat.37010. Epub 2017 Feb 15.
8
Independent Factors of Changes of Ankle-Brachial Index in Peripheral Arterial Occlusive Disease in Elderly Patients with or without Diabetes.老年外周动脉闭塞性疾病患者(伴或不伴糖尿病)踝臂指数变化的独立因素
Int J Environ Res Public Health. 2016 Nov 8;13(11):1103. doi: 10.3390/ijerph13111103.
9
YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes.YKL-40 在患有外周动脉疾病和糖尿病或糖尿病前期的患者中升高。
Atherosclerosis. 2012 Jun;222(2):557-63. doi: 10.1016/j.atherosclerosis.2012.03.034. Epub 2012 Apr 4.
10
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.在伴有和不伴有 2 型糖尿病的冠心病患者中,胆固醇流出能力与外周动脉疾病之间的关系:来自 CORDIOPREV 研究。
Cardiovasc Diabetol. 2021 Mar 25;20(1):72. doi: 10.1186/s12933-021-01260-3.

引用本文的文献

1
Development and validation of a nomogram for in-stent restenosis within 2 years in patients after iliac or femoral artery stent placement.髂动脉或股动脉支架置入术后患者2年内支架内再狭窄预测模型的建立与验证
BMC Surg. 2025 May 21;25(1):221. doi: 10.1186/s12893-025-02955-0.
2
Fibrinogen and Atherosclerotic Cardiovascular Diseases-Review of the Literature and Clinical Studies.纤维蛋白原与动脉粥样硬化性心血管疾病——文献综述和临床研究。
Int J Mol Sci. 2021 Dec 24;23(1):193. doi: 10.3390/ijms23010193.
3
Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels.

本文引用的文献

1
A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented?糖尿病患者截肢率的回顾性分析:能否进一步预防下肢截肢?
Cardiovasc Diabetol. 2012 Mar 2;11:18. doi: 10.1186/1475-2840-11-18.
2
Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial.腔内介入治疗糖尿病外周动脉闭塞性疾病的疗效:一项回顾性试验。
Cardiovasc Diabetol. 2012 Feb 28;11:17. doi: 10.1186/1475-2840-11-17.
3
Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study.
2型糖尿病患者的外周动脉疾病与纤维蛋白原水平升高有关。
Int J Endocrinol. 2018 Nov 8;2018:3709534. doi: 10.1155/2018/3709534. eCollection 2018.
4
Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.血清成纤维细胞生长因子21水平与中国女性糖尿病患者的下肢动脉粥样硬化疾病相关。
Cardiovasc Diabetol. 2015 Mar 11;14:32. doi: 10.1186/s12933-015-0190-7.
胰岛素抵抗增加了有明显动脉疾病但无已知糖尿病的患者新发心血管事件的发生。SMART 研究。
Cardiovasc Diabetol. 2011 Nov 21;10:100. doi: 10.1186/1475-2840-10-100.
4
Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation--the Hoorn Study.葡萄糖代谢受损和 2 型糖尿病与血液高凝状态有关:中心性肥胖和低度炎症的潜在作用——霍恩研究。
Thromb Res. 2012 May;129(5):557-62. doi: 10.1016/j.thromres.2011.07.033. Epub 2011 Aug 17.
5
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.血浆护骨素与颈动脉和外周动脉疾病有关,但与 2 型糖尿病心肌缺血无关。
Cardiovasc Diabetol. 2011 Aug 12;10:76. doi: 10.1186/1475-2840-10-76.
6
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.在 Bypass Angioplasty Revascularization Investigation 2 Diabetes(BARI 2D)试验中,胰岛素增敏策略对纤维蛋白溶解、抗血栓和抗炎的影响。
Circulation. 2011 Aug 9;124(6):695-703. doi: 10.1161/CIRCULATIONAHA.110.014860. Epub 2011 Jul 18.
7
Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study.他汀类药物和贝特类药物治疗对 2 型糖尿病炎症的影响。一项随机、交叉研究。
Diabetes Res Clin Pract. 2011 Jul;93(1):e25-8. doi: 10.1016/j.diabres.2011.03.009. Epub 2011 Mar 26.
8
Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.胰岛素和口服抗糖尿病药物对 2 型糖尿病患者糖代谢、血管功能障碍和骨骼肌炎症的影响。
Diabetes Metab Res Rev. 2011 May;27(4):373-82. doi: 10.1002/dmrr.1185.
9
Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia.辛伐他汀和非诺贝特对 2 型糖尿病伴混合性血脂异常患者细胞因子释放和全身炎症的影响。
Am J Cardiol. 2011 Apr 1;107(7):1010-1018.e1. doi: 10.1016/j.amjcard.2010.11.023. Epub 2011 Jan 26.
10
An update on markers of carotid atherosclerosis in patients with Type 2 diabetes.2 型糖尿病患者颈动脉粥样硬化标志物的最新研究进展。
Biomark Med. 2010 Aug;4(4):601-9. doi: 10.2217/bmm.10.79.